A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine-Case Report.
Anti-SARS-CoV-2 vaccine
COVID-19
Henoch-Schönlein purpura
Post-vaccinal vasculitis
Rheumatoid purpura
Vaccine secondary effects
Journal
SN comprehensive clinical medicine
ISSN: 2523-8973
Titre abrégé: SN Compr Clin Med
Pays: Switzerland
ID NLM: 101740833
Informations de publication
Date de publication:
2021
2021
Historique:
accepted:
09
07
2021
pubmed:
15
9
2021
medline:
15
9
2021
entrez:
14
9
2021
Statut:
ppublish
Résumé
In the COVID-19 pandemic era, anti-SARS-CoV-2 vaccination is considered to be the most efficient way to overtake the COVID-19 scourge. Like all medicines, vaccines are not devoid of risks and can in rare cases cause some various side effects. The objective of this case report is to highlight this unusual presentation of Henoch-Schönlein purpura following an anti-COVID-19 vaccination in a 62-year-old adult. The 62-year-old patient admitted to the emergency room for a petechial purpuric rash, sloping, occurring within hours, involving both legs and ascending. The clinical signs also included polyarthralgia and hematuria. Reported in the history the notion of an anti-COVID-19 vaccination 8 days prior to the onset of symptomatology. In the case of our patient, we retain the diagnosis of rheumatoid purpura based on the EULAR/PRINTO/PReS diagnostic criteria. Corticosteroid therapy (prednisone) was started, resulting to a rapid regression of clinical and laboratory symptoms, few days after the treatment. Patient was asymptomatic on subsequent visits. The low number of published cases of post-vaccine vasculitis does not question the safety of vaccines, but knowledge of such complications deserves to be known in order to avoid new immunizations that could have more serious consequences, and to avoid aggravating or reactivating a pre-existing vasculitis.
Identifiants
pubmed: 34518812
doi: 10.1007/s42399-021-01025-9
pii: 1025
pmc: PMC8425851
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2618-2621Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Conflict of InterestThe authors declare no competing interests.
Références
Dermatol Online J. 2021 Jan 15;27(1):
pubmed: 33560802
J Inflamm Res. 2021 Apr 16;14:1487-1510
pubmed: 33889008
Clin Med (Lond). 2019 Jan;19(1):77-79
pubmed: 30651252
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33748858
Am Fam Physician. 2020 Aug 15;102(4):229-233
pubmed: 32803924
Acta Derm Venereol. 2017 Nov 15;97(10):1160-1166
pubmed: 28654132
J Oral Pathol Med. 2021 Apr;50(4):424-427
pubmed: 33527524
Int J Dermatol. 2021 Aug;60(8):1032-1033
pubmed: 33928638
Clin Rheumatol. 2020 Nov;39(11):3223-3235
pubmed: 32885345
SN Compr Clin Med. 2020;2(11):2419-2422
pubmed: 33103062
Infect Drug Resist. 2021 Jan 19;14:151-161
pubmed: 33500636
Rev Med Interne. 2001 Feb;22(2):172-6
pubmed: 11234675
Ann Rheum Dis. 2010 May;69(5):798-806
pubmed: 20413568